Tesla is recording another decline in price after publishing its report on deliveries in Q1 2026. The company’s shares are down more than 3%. This extends an increasingly deep downtrend, since its peak in late 2025, Tesla has already lost over 25% of its market value.
- The company delivered 358,023 vehicles in the first quarter of 2026, coming in below market expectations and marking the second consecutive quarter in which the electric-car maker failed to meet forecasts.
- During the period, the company produced 408,386 vehicles, including 394,611 units of the Model 3 and Model Y and 13,775 vehicles from other model lines.
- The delivery mix consisted of 341,893 Model 3 and Model Y vehicles and 16,130 vehicles from other models, including the Model S, Model X, and Cybertruck.
- Overall deliveries rose 6.3% year over year; however, this was driven by the fact that Tesla temporarily halted Model Y production at several plants.
- Analysts had forecast average deliveries of around 370,000 vehicles. It is worth noting that this figure was additionally revised downward in the weeks leading up to the report’s release.
- Tesla also deployed 8.8 GWh of energy-storage products during the quarter.
Tesla is set to publish its full first-quarter financial results after the market closes on April 22. Many analysts still maintain a degree of optimism toward the stock, pointing to the approaching “robo-taxi” breakthrough. Recently, a bullish thesis for Tesla may also be a bet on rising demand for EVs amid a creeping fuel crisis.
Intuitive Machines: Flywheel of the space economy?
Anthropic leak and a cybersecurity sell-off
Unity up 10% 🚨 A revolution at the company?
Rivian - Partnership with Uber and the R2. Is it a "Tesla killer"?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
